Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

Author:

Lee Ho Young,Lee Grace,Ferguson Dianne,Hsu Shu-Hui,Hu Yue-HoungORCID,Huynh Elizabeth,Sudhyadhom Atchar,Williams Christopher L,Cagney Daniel N,Fitzgerald Kelly J,Kann Benjamin H,Kozono David,Leeman Jonathan E,Mak Raymond H,Han ZhaohuiORCID

Abstract

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (RPTV/Lungs) for both modalities, indicating that RPTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of RPTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; RPTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. RPTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

Publisher

IOP Publishing

Reference31 articles.

1. Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: a review from NRG oncology;Brandner;Med. Phys.,2017

2. Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance;Bryant;Frontiers in Oncology,2023a

3. Stereotactic magnetic resonance-guided adaptive and non-adaptive radiotherapy on combination MR-linear accelerators: current practice and future directions;Bryant;Cancers (Basel),2023b

4. Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors;Finazzi;Int. J. Radiat. Oncol. Biol. Phys.,2020a

5. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors;Finazzi;Radiother. Oncol.,2020b

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3